BioGend Therapeutics Co Ltd (ROCO:6733)
NT$ 36.85 -0.55 (-1.47%) Market Cap: 4.58 Bil Enterprise Value: 3.91 Bil PE Ratio: 0 PB Ratio: 4.88 GF Score: 51/100

BioGend Therapeutics Co Ltd (ROCO:6733) Transcripts

    • 1